Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Sell
3,455
-26
-0.7% -$3.04K 0.07% 146
2026
Q1
$419K Sell
3,481
-14,193
-80% -$1.64M 0.08% 139
2025
Q4
$1.96M Buy
17,674
+1,680
+11% +$158K 0.39% 79
2025
Q3
$1.35M Buy
15,994
+1,698
+12% +$140K 0.29% 83
2025
Q2
$1.13M Buy
14,296
+1,426
+11% +$113K 0.28% 82
2025
Q1
$1.16M Buy
12,870
+1,964
+18% +$183K 0.3% 86
2024
Q4
$1.08M Sell
10,906
-53,004
-83% -$5.46M 0.28% 85
2024
Q3
$7.26M Buy
63,910
+2,508
+4% +$298K 1.88% 7
2024
Q2
$7.6M Buy
61,402
+3,079
+5% +$397K 2.12% 4
2024
Q1
$7.33M Buy
58,323
+1,649
+3% +$203K 2.1% 5
2023
Q4
$6.18M Buy
56,674
+8,235
+17% +$855K 1.96% 6
2023
Q3
$4.86M Buy
48,439
+471
+1% +$50.8K 1.73% 10
2023
Q2
$5.54M Sell
47,968
-4,140
-8% -$470K 1.91% 6
2023
Q1
$5.54M Buy
52,108
+274
+0.5% +$29.6K 1.95% 6
2022
Q4
$5.64M Sell
51,834
-4,555
-8% -$466K 2.11% 4
2022
Q3
$4.86M Buy
56,389
+1,673
+3% +$149K 2.08% 7
2022
Q2
$4.99M Sell
54,716
-36,268
-40% -$3.22M 2.01% 6
2022
Q1
$7.87M Buy
90,984
+9,020
+11% +$711K 2.77% 3
2021
Q4
$6.28M Buy
81,964
+7,037
+9% +$560K 2.32% 4
2021
Q3
$5.63M Buy
74,927
+52,076
+228% +$3.96M 2.56% 4
2021
Q2
$1.78M Buy
22,851
+2,860
+14% +$213K 0.87% 48
2021
Q1
$1.47M Sell
19,991
-14,687
-42% -$1.08M 0.88% 46
2020
Q4
$2.71M Buy
34,678
+5,501
+19% +$421K 1.96% 9
2020
Q3
$2.31M Sell
29,177
-60
-0.2% -$4.7K 2.31% 9
2020
Q2
$2.16M Buy
+29,237
New +$2.2M 2.36% 9

Other funds holding MRK

Ellsworth Advisors's MRK Position: Q2 2026 in Review

Ellsworth Advisors reduced its Merck (MRK) stake by 0.75% in Q2 2026, selling an estimated $3.04K and leaving 3,455 shares worth $427K. The position accounts for 0.07% of the portfolio, ranked #146.

Ellsworth Advisors first reported a position in MRK in Q2 2020 and has held it in 25 quarters since. The position peaked at $7.87M in Q1 2022. 924 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ellsworth Advisors held 3,455 shares of Merck worth $427K as of Q2 2026.
  • Ellsworth Advisors sold 26 Merck shares in Q2 2026, an estimated $3.04K.
  • Merck made up 0.07% of Ellsworth Advisors's portfolio in Q2 2026, its #146 holding.
  • Ellsworth Advisors first reported a position in Merck in Q2 2020 and has held it in 25 quarters since.
  • Ellsworth Advisors's Merck position peaked at $7.87M in Q1 2022.
  • 924 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.